• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录组和表观基因组的综合分析显示 是胃癌的一个潜在生物标志物。

Integrated analysis of transcriptome and epigenome reveals as a potential biomarker in gastric cancer.

机构信息

Department of Genetics & Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, 8174673461, Isfahan, Iran.

Institute for Medical Informatics & Biometry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, 01307, Germany.

出版信息

Epigenomics. 2024 Feb;16(3):159-173. doi: 10.2217/epi-2023-0213. Epub 2024 Jan 29.

DOI:10.2217/epi-2023-0213
PMID:38282575
Abstract

Enhancer RNAs (eRNAs) are involved in gene expression regulation. Although functional roles of eRNAs in the pathophysiology of neoplasms have been reported, their involvement in gastric cancer (GC) is less known. A network-based integrative approach was utilized for analyzing transcriptome and epigenome alterations in GC, and an eRNA was selected for experimental validation. Survival analysis and clinicopathological associations were also performed. A hub eRNA, , showed significantly increased expression in tumor versus nontumor tissues, as well as an association with clinicopathological features. A seven-gene prognostic model was also constructed. The constructed network provides a comprehensive understanding of the underlying processes implicated in the progression of GC, along with a starting point from which to derive potential diagnostic/prognostic biomarkers.

摘要

增强子 RNA(eRNAs)参与基因表达调控。尽管已有研究报道 eRNAs 在肿瘤病理生理学中的功能作用,但它们在胃癌(GC)中的作用知之甚少。本研究采用基于网络的综合方法分析 GC 中的转录组和表观基因组改变,并选择 eRNA 进行实验验证。还进行了生存分析和临床病理关联分析。一个枢纽 eRNA ,在肿瘤与非肿瘤组织中表达显著增加,与临床病理特征相关。还构建了一个七基因预后模型。该构建的网络提供了对 GC 进展中涉及的潜在过程的全面理解,并为潜在的诊断/预后生物标志物提供了起点。

相似文献

1
Integrated analysis of transcriptome and epigenome reveals as a potential biomarker in gastric cancer.转录组和表观基因组的综合分析显示 是胃癌的一个潜在生物标志物。
Epigenomics. 2024 Feb;16(3):159-173. doi: 10.2217/epi-2023-0213. Epub 2024 Jan 29.
2
EMX2OS plays a prognosis-associated enhancer RNA role in gastric cancer.EMX2OS 在胃癌中发挥预后相关增强子 RNA 的作用。
Medicine (Baltimore). 2021 Oct 15;100(41):e27535. doi: 10.1097/MD.0000000000027535.
3
Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.整合生物信息学分析揭示胃癌中新型关键生物标志物和潜在候选小分子药物。
Pathol Res Pract. 2019 May;215(5):1038-1048. doi: 10.1016/j.prp.2019.02.012. Epub 2019 Feb 28.
4
Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.肺腺癌中功能性增强子RNA的综合表征揭示了新的调节因子和一种预后相关的分子亚型。
Theranostics. 2020 Sep 14;10(24):11264-11277. doi: 10.7150/thno.47039. eCollection 2020.
5
Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.通过非编码RNA相关竞争性内源RNA网络的综合分析鉴定胃癌相关潜在生物标志物
Clin Lab. 2018 Oct 1;64(10):1661-1669. doi: 10.7754/Clin.Lab.2018.180419.
6
Functional roles of antisense enhancer RNA for promoting prostate cancer progression.反义增强 RNA 在促进前列腺癌进展中的功能作用。
Theranostics. 2021 Jan 1;11(4):1780-1794. doi: 10.7150/thno.51931. eCollection 2021.
7
Identification of specific modules and hub genes associated with the progression of gastric cancer.鉴定与胃癌进展相关的特定模块和枢纽基因。
Carcinogenesis. 2019 Oct 16;40(10):1269-1277. doi: 10.1093/carcin/bgz040.
8
Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.长链非编码 RNA 与胃癌发病机制和预后关系的综合分析。
DNA Cell Biol. 2020 Feb;39(2):299-309. doi: 10.1089/dna.2019.5161. Epub 2020 Jan 14.
9
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.全面的基因组荟萃分析确定肿瘤内基质是预测胃癌患者生存的一个指标。
Gut. 2013 Aug;62(8):1100-11. doi: 10.1136/gutjnl-2011-301373. Epub 2012 Jun 26.
10
Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.整合分析鉴定 SLC5A6 和 MFAP2 为胃癌患者的新型诊断和预后生物标志物。
Int J Oncol. 2020 Feb;56(2):460-469. doi: 10.3892/ijo.2019.4944. Epub 2019 Dec 16.

引用本文的文献

1
A Current Perspective of Medical Informatics Developments for a Clinical Translation of (Non-coding)RNAs and Single-Cell Technologies.(非编码)RNA和单细胞技术临床转化的医学信息学发展现状
Methods Mol Biol. 2025;2883:31-51. doi: 10.1007/978-1-0716-4290-0_2.
2
Epigenetic Regulation of DNA Methylation and RNA Interference in Gastric Cancer: A 2024 Update.2024年胃癌中DNA甲基化和RNA干扰的表观遗传调控最新进展
Biomedicines. 2024 Sep 3;12(9):2001. doi: 10.3390/biomedicines12092001.